| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/29/1997 | US5624963 Process for removing bile salts from a patient and compositions therefor |
| 04/29/1997 | US5624957 Retinoid active compounds |
| 04/29/1997 | US5624953 Pharmaceutical compounds |
| 04/29/1997 | US5624949 Protein kinase C inhibitors |
| 04/29/1997 | US5624940 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
| 04/29/1997 | US5624935 Antidiabetic agents, hypoglycemic agents or antilipemic agents |
| 04/29/1997 | US5624921 Hypotriglyceridemic aminoacetylmercapto derivatives |
| 04/29/1997 | US5624903 Phosphoinositol-glycan-peptide with insulin-like action |
| 04/29/1997 | CA2021546C [r-(r*r*)]1-2-(4-fluorophenyl).beta.-.delta.-dihydroxy-5- (1-methylethyl-3-phenyl-4-[(phenylamino) carbonyl]-1h-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 04/24/1997 | WO1997008934A3 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/23/1997 | EP0769146A2 Screening for nuc inhibitors |
| 04/23/1997 | EP0769022A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 04/23/1997 | EP0769021A2 Transgenic fish in the treatment of diabetes |
| 04/23/1997 | EP0769005A2 Pla 2? inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 04/23/1997 | EP0768883A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 04/23/1997 | CN1148393A Bradykinin antagonist peptides incorporating N-substituted glycines |
| 04/22/1997 | US5623073 Benzimidazole compounds |
| 04/22/1997 | US5622987 Prevent migration or proliferation of smooth muscle cells |
| 04/22/1997 | US5622941 Administering the dosage form, nontoxic activated vitamin d; sustain release, side-effect reducation |
| 04/22/1997 | US5622934 Treating diabetes mellitus |
| 04/22/1997 | US5622779 Cellular factors that regulate the expression of genes encoding proteins involved in cholesterol homeostasis and methods of using same |
| 04/22/1997 | US5622721 Dosage forms of risedronate |
| 04/17/1997 | WO1997013770A1 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use |
| 04/17/1997 | WO1997013764A1 Lipophilic benzothiophenes |
| 04/17/1997 | WO1997013507A1 Use of creatine analogues for the treatment of disorders of glucose metabolism |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | WO1997013505A2 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 04/17/1997 | WO1997013500A2 LIPOSOME FORMULATIONS OF 5β STEROIDS |
| 04/17/1997 | WO1997013415A1 Therapeutic diet for dogs with lymphoma |
| 04/17/1997 | CA2234267A1 Lipophilic benzothiophenes |
| 04/17/1997 | CA2231561A1 Use of a .gamma.-rar-specific agonist ligand to increase apoptosis rate |
| 04/17/1997 | CA2208215A1 Liposome formulations of 5.beta. steroids |
| 04/16/1997 | EP0768379A1 Ubiquitous potassium-channel proteins and genes for the same |
| 04/16/1997 | EP0768308A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 04/16/1997 | EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 04/16/1997 | EP0768302A2 Hydroxypyridinones |
| 04/16/1997 | EP0768043A2 Diabetic nutritional product having controlled absorption of carbohydrate |
| 04/16/1997 | EP0767801A1 Endothelin antagonists ii |
| 04/16/1997 | EP0767794A1 Phosphinic acid derivatives |
| 04/16/1997 | EP0656780B1 Drugs containing diphosphonic acids and salts thereof |
| 04/16/1997 | CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/16/1997 | CN1147512A Substituted 4H-pyrans |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621098 Process for preparing bis-indolyl macrocycles |
| 04/15/1997 | US5621011 [α-tert.butyl aminomethyl)-3,4-dichlorobenzyl] thioacetamide, a procedure for its preparation and its uses |
| 04/15/1997 | US5621003 Maillard reaction inhibitor |
| 04/15/1997 | US5620996 Sulfonamidocarbonyl pyridine-2-carboxesteramides and their pyridine-N-oxide compounds and their use as pharmaceuticals |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620966 11,21-bisphenyl-19-norpregnane derivatives |
| 04/12/1997 | CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists |
| 04/10/1997 | WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 04/10/1997 | WO1997012963A2 A paf-acetylhydrolase and use in therapy |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012527A2 Use of threonine for the treatment of phenylketonuria |
| 04/10/1997 | WO1997000319A3 Chimeric leptin fused to immunoglobulin domain and use |
| 04/10/1997 | DE19537334A1 New piperidine carboxylic acid and pyrrolidine carboxylic acid derivs. |
| 04/10/1997 | DE19534602A1 Verwendung von Threonin zur Behandlung der Phenylketonurie Use of threonine for the treatment of phenylketonuria |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2233300A1 A paf-acetylhydrolase and use in therapy |
| 04/10/1997 | CA2232134A1 Use of threonine for the treatment of phenylketonuria |
| 04/10/1997 | CA2187392A1 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/09/1997 | EP0766966A2 Method of treating insulin resistance |
| 04/09/1997 | EP0766735A1 Class bi and ci scavenger receptors |
| 04/09/1997 | EP0766696A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 04/09/1997 | EP0766684A1 Endothelin receptor antagonists |
| 04/09/1997 | EP0766682A1 Protein kinase c inhibitors |
| 04/09/1997 | EP0766667A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 04/09/1997 | EP0766569A1 Aav capsid vehicles for molecular transfer |
| 04/09/1997 | CN1147254A Prodrugs of morpholine tachykinin receptor antagonists |
| 04/09/1997 | CN1147251A Tetrasubstd. imidazole derivs., method for preparing same, resulting intermediates, use thereof as drug, and pharmaceutical composition contg. same |
| 04/09/1997 | CN1034498C Octahydronaphthalene oxime derivs. for cholesterol biosynthesis inhibition, their preparation and use |
| 04/09/1997 | CN1034497C Process for preparation of aromatic amino-alcohol derivs. having antidiabetic and anti-obesity properties |
| 04/08/1997 | US5618850 Hydroxy-acid cosmetics |
| 04/08/1997 | US5618558 Fatty acid treatment |
| 04/08/1997 | US5618530 Quartenary polyallylamine |
| 04/03/1997 | WO1997011960A1 Antagonists of endothelin receptors |
| 04/03/1997 | WO1997011607A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | CA2232815A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/02/1997 | EP0765878A1 Heterocyclic aryl-, alkyl- and cycloalkylacetic acid amides |
| 04/02/1997 | EP0765867A1 Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them |
| 04/02/1997 | EP0765385A1 COMPOSITIONS AND METHOD OF STIMULATING THE PROLIFERATION AND DIFFERENTIATION OF HUMAN FETAL AND ADULT PANCREATIC CELLS $i(EX VIVO) |
| 04/02/1997 | EP0765336A1 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides |
| 04/02/1997 | EP0765330A1 Lactam inhibitors of cholesterol esterase |
| 04/02/1997 | EP0765327A1 Pyrazolo and pyrrolopyridines |
| 04/02/1997 | EP0765321A1 2-amino-3-aroyl-benzo beta thiophenes and method of making the same |
| 04/02/1997 | EP0765314A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 04/02/1997 | EP0765312A1 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption |
| 04/02/1997 | EP0765126A1 Therapeutic food composition and method to diminish blood sugar fluctuations |
| 04/02/1997 | EP0637958B1 Anti-obesity drugs |
| 04/02/1997 | EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 04/02/1997 | EP0535048B1 Use of derivatives of human bile-salt stimulated lipase for the preparation of medicaments |
| 04/02/1997 | CN1146765A Use of imidazole derivatives for treating disorders involving angiotensin receptors AT 1 and AT2, certain such products preparation thereof, use thereof as drugs, and pharmaceutical composition contai |
| 04/02/1997 | CN1034415C Method for prepn. of novel ascorbic acid derivatives |
| 04/01/1997 | US5616712 Skin disorders; anticarcinogenic and -inflammatory agents; autoimmune diseases; |
| 04/01/1997 | US5616684 Cyclic hexapeptide containing aspartic acid and derivatives, 2-thienylglycine, leucine, and tryptophan; endothelin receptor antagonist |
| 04/01/1997 | US5616560 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| 04/01/1997 | US5616352 Process for the production of fat- and cholesterol-reduced powered products based on eggs which are characterized by a high phospholipid content |
| 04/01/1997 | US5616123 Delivery of solid drug compositions |
| 04/01/1997 | CA2042426C Dietary fiber, its process and physiologically active composition containing the same as an active ingredient |
| 04/01/1997 | CA1339044C Insulin derivatives, the use thereof, and a pharmaceutical composition containing them |